Llwytho...
Pulmonary Outcomes Associated with Long-Term Azithromycin Therapy in Cystic Fibrosis
Rationale: Chronic azithromycin is commonly used in cystic fibrosis based on short controlled clinical trials showing reductions in pulmonary exacerbations and improved FEV(1). Long-term effects are unknown. Objectives: Examine pulmonary outcomes among chronic azithromycin users compared with matche...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Am J Respir Crit Care Med |
|---|---|
| Prif Awduron: | , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
American Thoracic Society
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7049934/ https://ncbi.nlm.nih.gov/pubmed/31661302 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1164/rccm.201906-1206OC |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|